risk – Pharma GMP

How to Justify In-Process Testing Frequency for Parenteral Products

digi — Wed, 26 Nov 2025 03:06:04 +0000

How to Justify In-Process Testing Frequency for Parenteral Products Step-by-Step Guide to Justify In-Process Testing Frequency for Parenteral Products In pharmaceutical manufacturing, in process checks for filled vials are a critical control point ensuring product safety, efficacy, and compliance with regulatory requirements. For parenteral products, any deviation or failure in in-process testing may compromise patient...

Handling Lost, Damaged or Missing GMP Records: Investigation Playbook

digi — Tue, 25 Nov 2025 18:30:04 +0000

Handling Lost, Damaged or Missing GMP Records: Investigation Playbook Step-by-Step Guide for Conducting a Missing GMP Records Investigation Good Manufacturing Practice (GMP) compliance depends heavily on accurate, comprehensive, and retrievable documentation. When GMP records go missing, are damaged, or lost, it threatens the integrity of quality systems and regulatory compliance. Effective handling of such incidents...

Risk Assessment of Extended Storage of Intermediates in Warehouse

digi — Tue, 25 Nov 2025 09:09:04 +0000

Risk Assessment of Extended Storage of Intermediates in Warehouse Step-by-Step Guide to Risk Assessment of Extended Storage of Intermediates in Warehouse The pharmaceutical manufacturing process relies heavily on the proper handling and storage of intermediates to ensure final product quality and patient safety. One common challenge encountered in pharmaceutical warehouses is the extended storage of...

Risk-Based Batch Release in Modern Pharmaceutical Quality Systems

digi — Mon, 24 Nov 2025 21:24:42 +0000

Risk-Based Batch Release in Modern Pharmaceutical Quality Systems Implementing Risk-Based Batch Release in Modern Pharmaceutical Quality Systems Batch release is a critical GMP activity ensuring that pharmaceutical products meet all predefined quality criteria before entering the market. In recent years, regulatory agencies including the FDA, EMA, and MHRA have encouraged adoption of risk based batch...

Risk Assessment Template for High Potency Product Manufacturing

digi — Mon, 24 Nov 2025 20:18:42 +0000

Risk Assessment Template for High Potency Product Manufacturing Comprehensive Step-by-Step Guide: Risk Assessment Template for High Potency Product Manufacturing High potency active pharmaceutical ingredient (HPAPI) manufacturing poses unique challenges that require stringent controls to ensure operator safety, product quality, and regulatory compliance. A well-structured risk assessment template high potency product is essential to identify, evaluate,...

Cross Contamination Risk Assessment: Practical Tools and Examples

digi — Mon, 24 Nov 2025 20:09:42 +0000

Cross Contamination Risk Assessment: Practical Tools and Examples Cross Contamination Risk Assessment: A Practical Step-by-Step Tutorial for Pharmaceutical Manufacturing Cross contamination represents a critical risk in pharmaceutical manufacturing, impacting product quality, patient safety, and regulatory compliance. An effective cross contamination risk assessment practical approach is essential for pharmaceutical manufacturers operating under stringent regulations such as...